Diplomat’s core specialty pharmacy performance is being negatively impacted by increased competition
The utilization of acronyms, jargon and common medical terms will continue within the healthcare industry. And like it or not, new terms will be introduced. The key for the entire industry is to encourage the use of clear language when communicating with non-clinician colleagues as well as with members
Provider Owned Commercial Health Plans. Provider-sponsored plans make up 15% or more of the health insurance market, and this percentage is growing, according to many of the projections by industry observers. Until recently, commercial health insurance products have, with only a few exceptions, been offered by health insurance companies. Now, health systems are increasingly assuming financial risk […]
Employer Perspectives Specialty Drug Step-Therapy Program Evaluation American Health and Drug Benefits, September 2016 Vol 9, No 6 – Industry Trends Matthew Harman, PharmD, MPH, Director, Clinical Pharmacy Strategies Employers Health, Columbus, OH F. Randy Vogenberg, PhD, RPh, Strategic Advisor and Co–Project Leader, Midwest Business Group on Health National Employer Biologics & Specialty Drug Initiative […]
Managed care pharmacy survey findings 2016 Managed Healthcare Executive September 26, 2016 To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, conducted its first-ever pharmacy survey during the second quarter of 2016. […]
Benefit Design – A Call to Action to Address Burden of Unintended Pregnancies in Plans’ Benefit Design F. Randy Vogenberg, PhD, RPh Partner, Access Market Intelligence, Greenville, SC Adjunct Professor of Pharmacy Administration, Presbyterian College School of Pharmacy, Clinton, SC Adjunct Instructor, Outcomes and Health Policy, University of Illinois at Chicago College of Pharmacy Originally […]